Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study

Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study

Pregnant women and newborns are considered a subgroup of population at increased risk for several infectious diseases, some of which are vaccine-preventable. Anti-diphtheria-tetanus-pertussis vaccine (dTpa) and influenza vaccine are recommended for pregnant women. We carried out a study to evaluate...

Full description

Bibliographic Details
Main Authors:	Francesco Paolo Bianchi, Pasquale Stefanizzi, Sabrina Lattanzio, Giusy Diella, Cinzia Annatea Germinario, Silvio Tafuri
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-01-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	influenza vaccine dtap vaccine mmr vaccine rubella torch complex pregnancy prevention
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2031698

Similar Items

Prevalence and management of rubella susceptibility in healthcare workers in Italy: A systematic review and meta-analysis
by: Francesco Paolo Bianchi, et al.
Published: (2022-12-01)

Immunity to rubella: an Italian retrospective cohort study
by: Francesco Paolo Bianchi, et al.
Published: (2019-11-01)

Response to third rubella vaccine dose
by: Lotta Siira, et al.
Published: (2018-10-01)

Vaccine-associated Rubella – a report of two cases and a review of the literature
by: Sean Wei Xiang Ong, et al.
Published: (2021-01-01)

An ecological analysis of socio-economic determinants associated with paediatric vaccination coverage in the Campania Region: A population-based study, years 2003–2017
by: Michelangelo Mercogliano, et al.
Published: (2024-06-01)

Efficacy of Rubella Vaccination after Co-Inoculation with Rhogam
by: Joshua S. Brunton, et al.
Published: (2023-08-01)

A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration
by: The MMR-158 Study Group
Published: (2019-04-01)

Measles, mumps and rubella vaccination coverage in capitals and interior region municipalities of Northeast Brazil: a household survey in a cohort of children born in 2017 and 2018
by: Adjoane Mauricio Silva Maciel, et al.
Published: (2024-12-01)

Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina
by: Carla Vizzotti, et al.
Published: (2023-03-01)

Raising Epidemiological Awareness: Assessment of Measles/MMR Susceptibility in Highly Vaccinated Clusters within the Hungarian and Croatian Population—A Sero-Surveillance Analysis
by: Dávid Szinger, et al.
Published: (2024-05-01)

Arm or Leg? The best site for injections in pediatric patients
by: Kennedy A. Sabharwal, et al.
Published: (2023-12-01)

The Effects of the COVID-19 Pandemic on Vaccination Hesitancy: A Viewpoint
by: Mirko Leonardelli, et al.
Published: (2023-07-01)

Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era
by: Malorie Perry, et al.
Published: (2023-03-01)

SÍNDROME DE RUBÉOLA CONGENITA: PRIMER CASO CLÍNICO EN CHILE POST PROGRAMA DE REVACUNACIÓN
by: Enrique Valdés R, et al.
Published: (2008-01-01)

Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy
by: Francesco Paolo Bianchi, et al.
Published: (2023-01-01)

Monitoring of adverse reaction of Haemophilus influenzae type b vaccine in Songjiang District， Shanghai
by: SHEN Jinhua, et al.
Published: (2022-11-01)

Could mandatory vaccination increase coverage in health-care Workers? The experience of Bari Policlinico General Hospital
by: Antonio Di Lorenzo, et al.
Published: (2021-12-01)

Factors Predicting Rubella Vaccination and Antibody in Pregnant Women in Japan: A Report from Pregnant Women Health Initiative
by: Akiko Iwata, et al.
Published: (2022-04-01)

Two-year antibody persistence in children vaccinated at 12–15 months with a measles-mumps-rubella virus vaccine without human serum albumin
by: Andrea A. Berry, et al.
Published: (2017-07-01)

Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study
by: The MMR-162 Study Group
Published: (2018-12-01)

Non-specific effects of MMR vaccines on infectious disease related hospitalizations during the second year of life in high-income countries: a systematic review and meta-analysis
by: Andrea Xaver Sinzinger, et al.
Published: (2020-03-01)

COVID-19 vaccination hesitancy among Italian parents: A systematic review and meta-analysis
by: Francesco Paolo Bianchi, et al.
Published: (2023-01-01)

Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA
by: Amy Parker Fiebelkorn, et al.
Published: (2013-09-01)

A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
by: Takashi Nakano, et al.
Published: (2018-12-01)

Safety Profile of Recommended Vaccinations in Adolescents: Data from Surveillance of Adverse Events Following Immunization in Puglia (Italy), 2016–2020
by: Antonio Di Lorenzo, et al.
Published: (2021-11-01)

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
by: Dong Li, et al.
Published: (2022-11-01)

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy
by: Yuguo Zhang, et al.
Published: (2022-11-01)

Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines
by: Md Ahsan Habib, et al.
Published: (2023-01-01)

Implementation of the preventive vacc ination program against measles, mumps, and rubella (MMR) on the example of a selected clinic in the city of Krakow
by: Marek Wojczyk, et al.
Published: (2020-06-01)

SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
by: N. D. Chernova, et al.
Published: (2012-08-01)

Adverse Events Following Measles-Mumps-Rubella-Varicella Vaccination and the Case of Seizures: A Post Marketing Active Surveillance in Puglia Italian Region, 2017–2018
by: Pasquale Stefanizzi, et al.
Published: (2019-10-01)

Voluntary termination of pregnancy: An opportunity for Measles, Mumps and Rubella vaccination in an Italian healthcare local unit
by: V. Pettinicchio, et al.
Published: (2018-04-01)

Use of M-M-R II outside of the routinely recommended age range – a systematic literature review
by: Manjiri Pawaskar, et al.
Published: (2022-01-01)

Low Prevalence of Mumps IgG Antibodies among the Paediatric Population Attending Tertiary Care Hospital in Southern India- A Pilot Study
by: Aridass Dhanasezhian, et al.
Published: (2023-06-01)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019-09-01)

PHARMACOECONOMIC ANALYSIS OF USE OF PENTAVALENT COMBINATION VACCINE WITH ACELLULAR PERTUSSIS COMPONENT IN THE FRAMEWORK OF THE REGIONAL IMMUNIZATION SCHEDULE OF KRASNODAR FOR ALL CHILDREN AGED 0–18 MONTHS AND SEPARATLY FOR CHILDREN AT RISK
by: A. Yu. Kulikov, et al.
Published: (2014-11-01)

Measles - an old children's disease to remember
by: Marta Custódio, et al.
Published: (2018-09-01)

Mitigating Vaccine Hesitancy and Building Trust to Prevent Future Measles Outbreaks in England
by: Sarah Thompson, et al.
Published: (2023-01-01)

Emergent lineages of mumps virus suggest the need for a polyvalent vaccine
by: Meghan May, et al.
Published: (2018-01-01)

Measles - a disease that should be a thing of the past, but returns
by: Katarzyna Głowacka, et al.
Published: (2019-04-01)